![]() |
市场调查报告书
商品编码
1918331
生物聚合物市场-2026-2031年预测Biopolymers Market - Forecast from 2026 to 2031 |
||||||
预计生物聚合物市场将维持 9.01% 的复合年增长率,从 2025 年的 160.46 亿美元成长到 2031 年的 269.27 亿美元。
生物聚合物是由玉米、甘蔗、木材和木材废弃物等可再生生物来源製成的聚合物。与传统的石油基塑胶不同,生物聚合物可生物降解,从而减少了其对环境污染和全球暖化的影响。随着各行各业和消费者对永续性重视,生物聚合物在包装、生物医学、製药和食品等众多领域的应用正在加速成长。对环保塑料,特别聚羟基烷酯(PHA)的塑料的需求正在增长,主要的包装和塑料製造商正在积极响应终端用户的需求,提供可生物降解的替代品。在医疗领域,PHA因其对各种类型损伤的优异创伤治疗性能而备受青睐。消费者对碳足迹和传统塑胶危害(例如化学物质渗入食品和饮料)的意识提升不断提高,进一步推动了人们对更安全、更天然材料的偏好。
市场成长的关键驱动因素反映了环境、监管和社会压力的综合作用。人们对传统塑胶有害影响的认识不断提高,推动了对生物聚合物的需求转变。生物聚合物来自天然物质,因此不会造成毒性暴露的风险。企业和消费者对更健康、更环保产品的需求进一步促进了市场成长。
世界各国政府的严格监管是推动这一趋势的主要因素。诸如禁止使用一次性塑胶製品和推广天然包装替代品等倡议旨在遏制废弃物堆积,随着人们对石化塑胶的生态危害认识不断加深,预计这一监管趋势还将继续。
消费者对生物分解性塑胶偏好的转变也是推动此成长的因素之一。生物聚合物在微生物的作用下能够迅速降解,并且比不可生物降解的材料更快地重新融入自然系统。人们对永续性意识的不断提高也进一步推动了对这类材料的需求。
医疗产业的成长也将成为另一个驱动力。生物聚合物在关节重建、心臟瓣膜、动脉、牙科零件、肌腱、韧带和人工水晶体等医疗设备中至关重要,它们能够修復或替换受损组织。医疗技术的进步和人口老化正在推动医疗设备产业的发展,从而导致对生物聚合物的需求不断增长。
从细分市场来看,包装应用这一终端用户领域预计将占据主导地位。包装是生物聚合物的主要用途,能够保护产品在储存和运输过程中免受损坏和污染。食品饮料、医药和消费品产业的快速普及,推动了生物聚合物的市场主导地位,而这又得益于消费者购买力的提升、人口成长以及电子商务的兴起。此外,环境问题、监管要求以及消费者对可再生资源取代石油基塑胶的需求,也加速了生物聚合物的普及,因为生物聚合物具有污染更少、降解速度更快的优势。
从区域来看,亚太地区预计将占据显着的市场份额并呈现强劲成长。这一主导地位归功于对永续材料日益增长的需求、不断增强的环保意识以及政府对生物基产品的支持政策。中国、日本和印度是主要的消费国,推动了包括包装、纺织、汽车和建筑在内的众多产业的应用。该地区丰富的农业资源,特别是甘蔗和玉米,提供了永续的原材料来源,而中国、泰国和马来西亚等国的大规模生产能力则为其提供了有力支撑。
我们的旗舰产品以性能和永续性的创新为特点。
Embalio 的 STANYL® B-MB 是一种 100% 生物基、物料平衡的高温聚酰胺树脂,在维持与化石基同类产品相同性能和特性的同时,可减少高达 50% 的碳足迹。本产品已获得 ISCC+ 认证,可在不影响工程性能的前提下,助力您实现永续性目标。
NatureWorks Ingeo® 生物聚合物 2003D 是一种透明的通用型挤出级热塑性塑料,由每年可再生资源製成。此高分子量塑胶专为生鲜食品包装和餐具而设计,可单独使用或与其他材料混合使用,并可在标准设备上轻鬆加工。
近期趋势表明,生物聚合物的功能性持续提高。
2023年4月,NatureWorks推出了Ingeo 6500D,这是一款专为卫生用品领域优化的不织布布。结合先进的亲水整理技术,它显着提升了产品的柔软度、强度和液体管理性能。 Ingeo 6500D经认证为可再生、低碳且生物基材料,满足了产业和消费者对永续材料日益增长的需求。
受传统塑胶监管日益严格、消费者主导永续性以及包装和医疗保健产业成长的推动,生物聚合物市场预计将持续扩张。亚太地区的资源优势和政策支持巩固了其领先地位。随着人们对传统塑胶健康和环境风险的认识不断提高,生物聚合物正成为向循环经济转型的重要推动力,它不仅性能与传统塑胶相当,而且对环境的影响显着降低。为了充分利用这一向生物基材料的模式转移转变,产业相关人员应优先考虑原料多样化、符合认证标准以及针对特定应用的创新。
企业使用我们的报告的目的是什么?
产业与市场分析、机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法规结构及影响、新产品开发、竞争情报
Biopolymers Market, sustaining a 9.01% CAGR, is anticipated to rise from USD 16.046 billion in 2025 to USD 26.927 billion in 2031.
Biopolymers are polymers produced from renewable biological feedstocks such as corn, sugarcane, timber, and wood waste. Unlike conventional petroleum-derived plastics, biopolymers are biodegradable, mitigating environmental pollution and contributions to global warming. Their adoption is accelerating as industries and consumers prioritize sustainability, with applications spanning packaging, biomedical, pharmaceutical, and food sectors. Heightened demand stems particularly from polyhydroxyalkanoates (PHA)-based eco-friendly plastics, as major packaging and plastics manufacturers respond to end-user requirements for biodegradable alternatives. In biomedical applications, biopolymers are valued for superior wound-healing properties across diverse injury types. Growing consumer awareness of carbon footprints and the hazards of traditional plastics-such as chemical leaching into food and beverages-further drives preference for these safer, natural-origin materials.
Key market growth drivers reflect converging environmental, regulatory, and societal pressures. Increasing recognition of conventional plastics' detrimental impacts is shifting demand toward biopolymers, which pose no risk of toxic exposure due to their natural composition. Enterprises and consumers alike seek healthier, lower-impact options, amplifying market momentum.
Stringent governmental regulations worldwide are a major catalyst. Initiatives banning single-use plastics and promoting natural packaging alternatives aim to curb waste accumulation, with this regulatory trend expected to persist amid greater acknowledgment of petrochemical plastics' ecological harm.
Shifting consumer preferences for biodegradable plastics reinforce expansion. Biopolymers degrade rapidly via microbial action, reintegrating into natural systems far quicker than non-biodegradable counterparts. Heightened sustainability awareness is channeling more demand toward these materials.
Healthcare sector growth provides additional impetus. Biopolymers are integral to medical devices-including joint replacements, heart valves, arteries, dental components, tendons, ligaments, and ocular lenses-facilitating repair or replacement of damaged tissues. Advancements in medical technology and aging demographics are propelling the medical device industry, consequently elevating biopolymer requirements.
From a segmental perspective, the packaging end-user category is projected to dominate market share. Packaging represents the primary application for biopolymers, safeguarding products against damage and contamination during storage and distribution. Surging utilization in food and beverage, pharmaceutical, and consumer goods sectors-driven by rising purchasing power, population growth, and e-commerce proliferation-underpins this leadership. Environmental concerns, regulatory mandates, and consumer demand for renewable-sourced alternatives over petroleum-based plastics further accelerate adoption, as biopolymers offer reduced pollution and faster degradation.
Geographically, Asia Pacific is anticipated to command a substantial market portion and exhibit robust growth. This dominance arises from escalating demand for sustainable materials, mounting environmental consciousness, and supportive government policies favoring bio-based products. Major consumers include China, Japan, and India, where applications span packaging, textiles, automotive, and construction. The region's abundant agricultural resources-particularly sugarcane and corn-provide sustainable feedstocks, complemented by significant production capacities in countries like China, Thailand, and Malaysia.
Leading product offerings highlight innovations in performance and sustainability.
Envalior's STANYL(R) B-MB is a 100% bio-based, mass-balanced high-temperature polyamide that achieves up to a 50% reduced carbon footprint while retaining identical performance, features, and quality to its fossil-based counterpart. ISCC+-certified, it supports customer sustainability goals without compromising engineering properties.
NatureWorks' Ingeo biopolymer 2003D is a transparent, general-purpose extrusion-grade thermoplastic resin derived from annually renewable resources. Specifically formulated for fresh food packaging and serviceware, this high molecular weight grade processes easily on standard equipment, either standalone or in blends.
Recent developments underscore ongoing enhancements in biopolymer functionality.
In April 2023, NatureWorks introduced Ingeo 6500D, a grade optimized for nonwovens in hygiene applications. When combined with advanced hydrophilic finishes, it delivers improved softness, strength, and fluid management. Certified as renewably sourced, low-carbon, and biobased, Ingeo 6500D addresses escalating industry and consumer demands for sustainable material options.
The biopolymers market is poised for sustained expansion, propelled by regulatory enforcement against conventional plastics, consumer-driven sustainability preferences, and sectoral growth in packaging and healthcare. Asia Pacific's resource advantages and policy support solidify its vanguard position. As awareness of traditional plastics' health and environmental risks intensifies, biopolymers emerge as a critical enabler of circular economy transitions, offering comparable performance with markedly lower ecological impact. Industry stakeholders should prioritize feedstock diversification, certification compliance, and application-specific innovations to capitalize on this shifting paradigm toward bio-based materials.
What do businesses use our reports for?
Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence